{"id":"https://openalex.org/W3136988147","doi":"https://doi.org/10.3389/fonc.2021.610952","title":"Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers","display_name":"Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers","publication_year":2021,"publication_date":"2021-03-15","ids":{"openalex":"https://openalex.org/W3136988147","doi":"https://doi.org/10.3389/fonc.2021.610952","mag":"3136988147","pmid":"https://pubmed.ncbi.nlm.nih.gov/33791204","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8005657"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2021.610952","doi":"https://doi.org/10.3389/fonc.2021.610952","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.610952","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.610952/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.610952/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076550697","display_name":"Atsuto Mouri","orcid":"https://orcid.org/0000-0001-8704-8151","observed_orcids":["https://orcid.org/0000-0001-8704-8151"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Atsuto Mouri","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033780369","display_name":"Kyoichi Kaira","orcid":"https://orcid.org/0000-0001-5548-7686","observed_orcids":["https://orcid.org/0000-0001-5548-7686"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kyoichi Kaira","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039962714","display_name":"Ou Yamaguchi","orcid":"https://orcid.org/0000-0001-7194-6459","observed_orcids":["https://orcid.org/0000-0001-7194-6459"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ou Yamaguchi","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070064742","display_name":"Kosuke Hashimoto","orcid":"https://orcid.org/0000-0001-7627-7901","observed_orcids":["https://orcid.org/0000-0001-7627-7901"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kosuke Hashimoto","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078969338","display_name":"Yu Miura","orcid":"https://orcid.org/0000-0002-2752-5873","observed_orcids":["https://orcid.org/0000-0002-2752-5873"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yu Miura","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018407349","display_name":"Ayako Shiono","orcid":"https://orcid.org/0000-0001-6546-3864","observed_orcids":["https://orcid.org/0000-0001-6546-3864"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ayako Shiono","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064312304","display_name":"Shun Shinomiya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shun Shinomiya","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024253530","display_name":"Tomoe Akagami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoe Akagami","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035023922","display_name":"Hisao Imai","orcid":"https://orcid.org/0000-0003-3097-4255","observed_orcids":["https://orcid.org/0000-0003-3097-4255"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisao Imai","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029655825","display_name":"Kunihiko Kobayashi","orcid":"https://orcid.org/0000-0002-6468-9068","observed_orcids":["https://orcid.org/0000-0002-6468-9068"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kunihiko Kobayashi","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007350359","display_name":"Hiroshi Kagamu","orcid":"https://orcid.org/0000-0003-4523-8517","observed_orcids":["https://orcid.org/0000-0003-4523-8517"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Kagamu","raw_affiliation_strings":["Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076550697"],"corresponding_institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.0004,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.77316649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"11","issue":null,"first_page":"610952","last_page":"610952"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.9359999895095825},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/antinuclear-antibodies","display_name":"antinuclear antibodies","score":0.9570000171661377},{"id":"https://openalex.org/keywords/autoantibodies","display_name":"autoantibodies","score":0.8330000042915344},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.875},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7379999756813049},{"id":"https://openalex.org/keywords/ana-titer","display_name":"ANA titer","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8573367595672607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6780551075935364},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6470454335212708},{"id":"https://openalex.org/C149443304","wikidata":"https://www.wikidata.org/wiki/Q185390","display_name":"Anti-nuclear antibody","level":4,"score":0.6284074187278748},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5846468210220337},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.555267333984375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5339658856391907},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5186618566513062},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.47540101408958435},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.439158171415329},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.4302997887134552},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.4084283709526062},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35364094376564026},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3376956582069397},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32224681973457336},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31390902400016785}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2021.610952","doi":"https://doi.org/10.3389/fonc.2021.610952","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.610952","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.610952/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:33791204","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33791204","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8005657","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8005657/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c72ee9d9108a4521a7bb1a0d5abbc77b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c72ee9d9108a4521a7bb1a0d5abbc77b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 11 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2021.610952","doi":"https://doi.org/10.3389/fonc.2021.610952","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.610952","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.610952/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G8382569582","display_name":"Development of Breakthrough Immune Checkpoint Inhibitory Therapy Using Novel Immunological Biomarkers","funder_award_id":"17H04184","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3136988147.pdf","grobid_xml":"https://content.openalex.org/works/W3136988147.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1756044145","https://openalex.org/W1975230923","https://openalex.org/W2019607817","https://openalex.org/W2021988356","https://openalex.org/W2085601342","https://openalex.org/W2087323512","https://openalex.org/W2104347254","https://openalex.org/W2113523651","https://openalex.org/W2125616358","https://openalex.org/W2156353875","https://openalex.org/W2166662937","https://openalex.org/W2203939782","https://openalex.org/W2222086386","https://openalex.org/W2416974268","https://openalex.org/W2527905628","https://openalex.org/W2567564314","https://openalex.org/W2572174216","https://openalex.org/W2781601010","https://openalex.org/W2800772239","https://openalex.org/W2908431216","https://openalex.org/W2912065177","https://openalex.org/W2945990435","https://openalex.org/W2979133982"],"related_works":["https://openalex.org/W4286558533","https://openalex.org/W2912065177","https://openalex.org/W2979133982","https://openalex.org/W4390470014","https://openalex.org/W7212686741","https://openalex.org/W3105335045","https://openalex.org/W2979973674","https://openalex.org/W4380896636","https://openalex.org/W3138602941","https://openalex.org/W2982224347"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2],"inhibitor":[3],"(ICI)":[4],"therapy":[5],"has":[6,210],"been":[7],"described":[8],"to":[9,207],"markedly":[10],"improve":[11],"patient":[12],"survival.":[13],"However,":[14,167],"reports":[15],"describing":[16],"the":[17,35,95,122,135,143,153,178,186,199,219,228],"antitumor":[18],"therapeutic":[19],"efficacy":[20,36,169],"and":[21,37,58,64,83,92,103],"safety":[22],"of":[23,39,94,121,134,177,180,188,205,215],"ICIs":[24,40,72,206],"in":[25,41,142,152,173,218,227],"patients":[26,45,97,124,161,189,209],"with":[27,46,71],"autoantibodies":[28],"are":[29],"scarce.":[30],"Methods":[31],"This":[32],"study":[33],"examined":[34],"feasibility":[38],"antinuclear":[42],"antibody":[43],"(ANA)-positive":[44],"non-small":[47],"cell":[48],"lung":[49],"cancer":[50],"(NSCLC).":[51],"An":[52],"ANA":[53,107,165,181],"titer":[54],"greater":[55],"than":[56,132,225],"1:40":[57],"1:80":[59],"was":[60,112,125,129,146,170,222],"defined":[61],"as":[62],"positive":[63,106],"high,":[65],"respectively.":[66],"Patients":[67],"who":[68,99,190],"were":[69,86,194],"treated":[70],"at":[73],"Saitama":[74],"Medical":[75,78],"University,":[76],"International":[77],"Center":[79],"between":[80,198],"January":[81],"2016":[82],"December":[84],"2018":[85],"retrospectively":[87],"reviewed.":[88],"Results":[89],"One":[90],"hundred":[91],"nineteen":[93],"266":[96],"(44.7%)":[98],"received":[100],"nivolumab,":[101],"pembrolizumab,":[102],"atezolizumab":[104],"had":[105,163],"titers.":[108,166],"Their":[109],"median":[110,139],"age":[111],"69":[113],"(range,":[114],"39\u201384)":[115],"years.":[116],"The":[117,138,203,213],"overall":[118],"response":[119],"rate":[120,187],"ANA-positive":[123,144,160,208,220],"35.9%":[126],"(37/103),":[127],"which":[128],"not":[130,171,195,223],"less":[131],"that":[133,226],"ANA-negative":[136,154,229],"group.":[137,230],"progression-free":[140],"survival":[141],"group":[145,155,221],"6.3":[147],"months":[148,151],"versus":[149],"4.3":[150],"(p":[156],"=":[157],"0.08).":[158],"Twenty-seven":[159],"(10.2%)":[162],"high":[164],"ICI":[168],"decreased":[172],"these":[174],"patients.":[175],"Regardless":[176],"cutoff":[179],"titers":[182],"(1:40":[183],"or":[184],"1:80),":[185],"experienced":[191],"adverse":[192,216],"events":[193,217],"significantly":[196],"different":[197],"two":[200],"groups.":[201],"Conclusion":[202],"administration":[204],"clinical":[211],"benefits.":[212],"prevalence":[214],"higher":[224]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-03-29T00:00:00"}